These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12766857)

  • 1. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
    Rahim S; Pillai SK; Gold HS; Venkataraman L; Inglima K; Press RA
    Clin Infect Dis; 2003 Jun; 36(11):E146-8. PubMed ID: 12766857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.
    Bonora MG; Solbiati M; Stepan E; Zorzi A; Luzzani A; Catania MR; Fontana R
    J Clin Microbiol; 2006 Mar; 44(3):1153-5. PubMed ID: 16517918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
    Dobbs TE; Patel M; Waites KB; Moser SA; Stamm AM; Hoesley CJ
    J Clin Microbiol; 2006 Sep; 44(9):3368-70. PubMed ID: 16954275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.
    Raad II; Hanna HA; Hachem RY; Dvorak T; Arbuckle RB; Chaiban G; Rice LB
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3583-5. PubMed ID: 15328133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
    Pai MP; Rodvold KA; Schreckenberger PC; Gonzales RD; Petrolatti JM; Quinn JP
    Clin Infect Dis; 2002 Nov; 35(10):1269-72. PubMed ID: 12410489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.
    Souli M; Sakka V; Galani I; Antoniadou A; Galani L; Siafakas N; Zerva L; Fytrou H; Tsiodras S; Giamarellou H
    Int J Antimicrob Agents; 2009 Feb; 33(2):137-42. PubMed ID: 19013056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
    Herrero IA; Issa NC; Patel R
    N Engl J Med; 2002 Mar; 346(11):867-9. PubMed ID: 11893808
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
    Johnson AP; Tysall L; Stockdale MV; Woodford N; Kaufmann ME; Warner M; Livermore DM; Asboth F; Allerberger FJ
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):751-4. PubMed ID: 12415476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
    Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
    J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates.
    Cilli F; Pullukcu H; Aydemir S; Sipahi OR; Tasbakan M; Turhan A; Ulusoy S
    Int J Antimicrob Agents; 2008 Mar; 31(3):297-8. PubMed ID: 18180144
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
    Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
    Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
    Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging linezolid-resistant, vancomycin resistant Enterococcus faecium from a patient of a haematological unit in Poland.
    Krawczyk B; Samet A; Bronk M; Hellmann A; Kur J
    Pol J Microbiol; 2004; 53(3):193-6. PubMed ID: 15702920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed discovery of linezolid-resistant, vancomycin-resistant Enterococcus faecium: lessons learned.
    Schwartz MD; Shive DK; Shaikh ZH
    Clin Infect Dis; 2004 Jan; 38(1):155-6. PubMed ID: 14679466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
    Afşar I; Barış I; Sener AG; Köksal V; Demirci M
    Mikrobiyol Bul; 2012 Jul; 46(3):516-8. PubMed ID: 22951666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
    Ntokou E; Stathopoulos C; Kristo I; Dimitroulia E; Labrou M; Vasdeki A; Makris D; Zakynthinos E; Tsakris A; Pournaras S
    J Antimicrob Chemother; 2012 Aug; 67(8):1819-23. PubMed ID: 22532462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M; Wixson RL; Pertel PE
    Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
    Liao CH; Tseng SP; Fang CT; Teng LJ; Hsueh PR
    J Antimicrob Chemother; 2005 Apr; 55(4):598-9. PubMed ID: 15728149
    [No Abstract]   [Full Text] [Related]  

  • 20. Linezolid-resistant enterococci in Greece: epidemiological characteristics.
    Spiliopoulou I; Damani A; Chini V; Zerva L; Kolonitsiou F; Anastassiou ED; Petinaki E
    Chemotherapy; 2011; 57(3):181-5. PubMed ID: 21474928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.